The 3-(3-oxoisoindolin-1-yl)pentane-2,4-dione (ISOAC1) as a new molecule able to inhibit Amyloid β aggregation and neurotoxicity.
Alzheimer’s disease
Amyloid β 1–42 aggregation
Neuroprotection
β-diketone-3-substituted isoindolinone
Journal
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
23
08
2023
revised:
12
10
2023
accepted:
16
10
2023
medline:
15
11
2023
pubmed:
24
10
2023
entrez:
23
10
2023
Statut:
ppublish
Résumé
Amyloid β 1-42 (Aβ
Identifiants
pubmed: 37871561
pii: S0753-3322(23)01543-3
doi: 10.1016/j.biopha.2023.115745
pii:
doi:
Substances chimiques
Amyloid beta-Peptides
0
pentane
4FEX897A91
Pentanes
0
Peptide Fragments
0
Protein Aggregates
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
115745Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that there are no conflicts of interests.